Budget Impact of Albumin-Bound Paclitaxel + Gemcitabine in the Treatment of Metastatic Pancreatic Cancer von Binder, G, Whiting, S, Milentijevic, D, Penenberg, D, Wei, X, Kayitalire, L, Renschler, M.F

Volltext

Magnitude of Benefit and Costs for Recent Solid Tumor Agents von Binder, G, Milentijevic, D, Squier, M, Whiting, S, Brown, G, Renschler, M.F

Volltext

PCV44 Real-World Assessment of the Use of Anti-platelet Therapy for Recurrent Stroke Prevention in US Patients without Atrial Fibrillation with Recent Ischemic Stroke or Transient... von O'Brien, E., Milentijevic, D., Roychowdhury, R., Mitra, S., Chen, Y.W.

Volltext

HSD63 Real-World Data Analysis of Genetic Testing for Inherited Retinal Diseases von Lee, C.H., Liu, J., Kumar, P., Pranshu, J., Stahl, Hengst, S., Milentijevic, D.

Volltext

HSD42 Utilization and Cost of Molecular Diagnostics and Genetic Testing Prescribed By Various Medical Specialties in the United States von Lee, C.H., Liu, J., Kumar, P., Pranshu, J., Stahl, Hengst, S., Milentijevic, D.

Volltext

PCR173 Health State Utilities Associated With X-Linked Retinitis Pigmentosa in the United States von Matza, L, Li, N, Stewart, K, Hashim, M, Pan, F, Zhang, Q, Milentijevic, D, Lee, CH, Michaelides, M, Scholl, H

Volltext

P287Use of machine learning to determine stroke severity of patients diagnosed with stroke in claims data von Kogan, E, Twyman, K, Heap, J, Milentijevic, D, Lin, J H, Chen, Y.-W, Alberts, M

Volltext

P3847Risk of stroke overall and by stroke severity among newly diagnosed non-valvular atrial fibrillation patients initiating treatment with rivaroxaban versus warfarin von Alberts, M, Lin, J H, Chen, Y.-W, Ding, Z, Bisht, D, Kogan, E, Twyman, K, Milentijevic, D

Volltext

Influence of stress rate on water loss, matrix deformation and chondrocyte viability in impacted articular cartilage von Milentijevic, Dejan, Torzilli, Peter A.

Volltext

PCN40 - Budget Impact of Albumin-Bound Paclitaxel + Gemcitabine in the Treatment of Metastatic Pancreatic Cancer von Binder, G., Whiting, S., Milentijevic, D., Penenberg, D., Wei, X., Kayitalire, L., Renschler, M.F.

Volltext

PCN11 - Magnitude of Benefit and Costs for Recent Solid Tumor Agents von Binder, G., Milentijevic, D., Squier, M., Whiting, S., Brown, G., Renschler, M.F.

Volltext

An In Vivo Rabbit Model for Cartilage Trauma: A Preliminary Study of the Influence of Impact Stress Magnitude on Chondrocyte Death and Matrix Damage von Milentijevic, Dejan, Rubel, Iván F, Liew, Allan S. L, Helfet, David L, Torzilli, Peter A

Volltext

Influence of Stress Magnitude on Water Loss and Chondrocyte Viability in Impacted Articular Cartilage von Milentijevic, Dejan, Helfet, David L, Torzilli, Peter A

Volltext

Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States von Peacock, W. Frank, Crawford, James M., Chen, Yen-Wen (Cindy), Ashton, Veronica, Campbell, Alicia K., Milentijevic, Dejan, Spyropoulos, Alex C.

Volltext

Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels von Khorana, Alok A., Kuderer, Nicole M., McCrae, Keith, Milentijevic, Dejan, Germain, Guillaume, Laliberté, François, MacKnight, Sean D., Lefebvre, Patrick, Lyman, Gary H., Streiff, Michael B.

Volltext

Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis von Costa, Olivia S., Beyer-Westendorf, Jan, Ashton, Veronica, Milentijevic, Dejan, Moore, Kenneth Todd, Bunz, Thomas J., Coleman, Craig I.

Volltext

Health-care Cost Comparison of Rivaroxaban and Warfarin Use for VTE von Baugh, Christopher, MD, Coleman, Craig, PharmD, Crivera, Concetta, PharmD, Milentijevic, Dejan, PhD, Wang, Sheng-Wei, PhD, Lu, Lang, MS, Nelson, Winnie, PharmD

Volltext

Cancer Associated Thrombosis Is Associated with Higher Mortality across All Khorana Score Risk Levels von Khorana, Alok A, McCrae, Keith R, Kuderer, Nicole M., Milentijevic, Dejan, Laliberté, François, Germain, Guillaume, MacKnight, Sean D., Lefebvre, Patrick, Lyman, Gary H., Streiff, Michael B.

Volltext

Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US von Milentijevic, Dejan, Germain, Guillaume, Laliberté, François, Bookhart, Brahim K., MacKnight, Sean D., Tsang, Jenkin, Lefebvre, Patrick

Volltext

Healthcare costs of patients with cancer stratified by Khorana score risk levels von Khorana, Alok A., Kuderer, Nicole M., McCrae, Keith, Milentijevic, Dejan, Germain, Guillaume, Laliberté, François, MacKnight, Sean D., Lefebvre, Patrick, Lyman, Gary H., Streiff, Michael B.

Volltext